Mete Güler

Mete Güler

Auto-generated profile, based on publicly available information

Mete Güler

Özel Hatem Hastanesi, Göz Hastalıkları Kliniği

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Korean Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MGMete Güler
Mete Güler
BBBurak Bilgin
Burak Bilgin
MÇMusa Çapkın
Musa Çapkın
AŞAli Şimşek
Ali Şimşek
ŞBŞemsettin Bilak
Şemsettin Bilak
Güler M, et al. Korean J Ophthalmol. 2015 Jun;29(3):190-194. http://dx.doi.org/10.3341/kjo.2015.29.3.190

1 April 2009 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
MGMete Güler
Mete Güler
TYTurgut Yilmaz
Turgut Yilmaz
IÖİbRahim Özercan
İbRahim Özercan
TETamer Elkiran
Tamer Elkiran

17 November 2010 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
GMGüler Mete
Güler Mete
YTYılmaz Turgut
Yılmaz Turgut
AOArslanhan Osman
Arslanhan Osman
ÜGÜlkü Gülşen
Ülkü Gülşen
AHArtaş Hakan
Artaş Hakan
Intraocular foreign body (IOFB) is a common association of penetrating ocular trauma. Early diagnosis and removal of IOFBs especially if they are metallic is very important to determine further management and the final result of treatment. Missed IOFB may present in different clinical aspects that may limit its detection and symptoms may only become apparent after a prolonged period of time. We report a case of a missed metallic intraocular foreign body in the anterior chamber over a 2-year period without causing severe inflammatory reaction and presented with uveitis later. A 42-year-old man presented with a progressive blurring of vision, pain, photophobia, and redness in the left eye for 3 months. He had a history of traffic accident 2 years ago and he was accepted to intensive care unit for 3 days. Three months ago, in another center, he was admitted to hospital for 1 week and intravitreal antibiotics and medical treatment were given for pain, photophobia, and redness in his left eye. In five o’ clock meridian of the angle, there was an IOFB coated with hypopyon was observed under biomicrocopic magnification. Plain X-ray and computed tomography confirmed the foreign body in the left eye. After obtaining informed consent from the patient, the foreign body was removed under local anesthesia.

12 June 2020 in Neuro-Ophthalmology
Verified
Journal Article
Open access
ÖGÖzlem Güler
Özlem Güler
MGMete Güler
Mete Güler
CYCemile Buket Tuğan Yıldız
Cemile Buket Tuğan Yıldız
HHHakan Hakkoymaz
Hakan Hakkoymaz
Migraine pathophysiology is complex and partially includes the vasculature. This study compared retinal and peripapillary blood flow parameters in migraine patients during an attack with healthy controls using optical coherence tomography angiography (OCTA). A prospective clinical study was conducted including 52 eyes from 26 migraineurs and 48 eyes from 24 healthy controls. OCTAs were performed with RTVue XR Avanti using AngioVue software. OCTA imaging was performed during the attack period in migraineurs before any treatment for the attack. Vascular densities in the whole image, fovea, superior hemisphere, inferior hemisphere, and temporal, superior, nasal, and inferior regions of the parafoveal area and in the superficial and deep capillary plexuses were acquired and statistically analysed. The flow density parameters were measured in the superficial retinal capillary plexus, deep retinal capillary plexus, outer retinal capillary plexus, and choriocapillaris layers of the macula in a 3-mm diameter area. The peripapillary flow densities were measured for the optic nerve head, vitreous, radial peripapillary capillaries, and choroid in a 4.50-mm diameter area around the optic disc. Vascular density measurements in the superficial plexus were similar between migraineurs and controls (p > .05). Vascular densities in the deep capillary plexus were similar between groups (p > .05), except in the deep superior area (p = .05). Flow areas in the nerve head, vitreous, peripapillary capillary, and choroid segments were similar between migraineurs and controls (p > .05). Macular thickness parameters were also similar between groups (p > .05). The results suggest that an acute migraine attack does not affect retinal or peripapillary blood flow.

3 March 2014 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
MGMete Güler
Mete Güler
MÇMusa Çapkın
Musa Çapkın
AŞAli Şimşek
Ali Şimşek
ŞBŞemsettin Bilak
Şemsettin Bilak
BBBurak Bilgin
Burak Bilgin
MFMüge Fırat
Müge Fırat
Purpose: To determine the short-term effects of single-dose intravitreal bevacizumab injection on central corneal thickness (CCT), simulated keratometry (Sim K), anterior chamber depth (ACD), iridocorneal angle (ICA) and intraocular pressure (IOP) measurements. Design: Prospective, nonrandomized, interventional clinical trial. Materials and Methods: Forty-three eyes of 43 patients aged between 41 and 78 years (average 62 ± 13 years) received an intravitreal injection of 2.5 mg/0.1 mL bevacizumab. Patients who had not undergone additional intravitreal anti-vascular endothelial growth factor therapy within 6 months were included in the study. CCT, Sim K, ACD and ICA measurements were obtained with Sirius Topographer. IOP measurements were taken after topographic measurements with Goldmann applanation tonometer. The CCT, ACD, ICA and IOP measurements were taken before and after 3rd, 15th days and 1st month of intravitreal bevacizumab injection. Results: Pre- and postinjection of 3rd, 15th days and 1st month CCT (p = 0.999), Sim K (p = 0.746), ACD (p = 0.996), ICA (p = 0.632) and IOP (p = 0.707) measurements were not statistically different. Mean CCT (p = 1.000), Sim K (0.972), ACD (p = 0.998), ICA (0.667) and IOP (0.951) values were similar before and after 3rd day of bevacizumab injection. Mean CCT (p = 0.999), Sim K (p = 0.994), ACD (p = 1.000), ICA (p = 0.999) and IOP (p = 1.000) measurements were also similar before and after 15th day of injection. Preinjection and 1st month of postinjection CCT (p = 0.999), Sim K (p = 0.932), ACD (p = 0.998), ICA (p = 1.000) and IOP (p = 0.741) measurements did not change significantly. Conclusions: Single-dose intravitreal bevacizumab injection does not affect CCT, Sim K, ACD, ICA and IOP in short-term period.